Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference – Rapidly transforming into a leading global biopharma company GlobeNewswire January 09, 2026 COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones. […]

ROSEN, A TOP-RANKED LAW FIRM, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR)

(TSX-V:RECO),(OTC US:RECAF),(Other OTC:RECAF),(Boerse Frankfurt – Freiverkehr:0XD), CALGARY, Alberta, Jan. 09, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan with Odyssey Trust Company as Rights Agent effective today. The Shareholder

(NASDAQ:SLNO), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

ReconAfrica Announces Adoption of Shareholder Rights Plan GlobeNewswire January 09, 2026 CALGARY, Alberta, Jan. 09, 2026 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company”, “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the Board of Directors of the Company has adopted a Shareholder Rights Plan with Odyssey Trust Company as Rights

SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company's and/or members of its senior management's possible violation

(NasdaqGM:GAUZ), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline. SO WHAT: If you

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GAUZ GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025

Fannin Partners has been awarded a $300,000 Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute (NEI) to advance a first-in-class, non-VEGF-targeted therapeutic for wet age-related macular degeneration (wet AMD), targeting a disease-selective angiogenic pathway in patients who fail to benefit from standard anti-VEGF therapy. Fannin Partners has been awarded a